<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 18_3-4_89-90</article-id>
<article-id pub-id-type="doi">10.15836/ccar2023.89</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Fully percutaneous transaxillary approach for transcatheter aortic valve implantation: initial experience from Split</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6639-5971</contrib-id><name><surname>Runji&#x0107;</surname><given-names>Frane</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9882-9145</contrib-id><name><surname>Kristi&#x0107;</surname><given-names>Ivica</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1399-3406</contrib-id><name><surname>Crn&#x010D;evi&#x0107;</surname><given-names>Nikola</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2700-2121</contrib-id><name><surname>Zanchi</surname><given-names>Jak&#x0161;a</given-names></name></contrib>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9272-6906</contrib-id><name><surname>Mateti&#x0107;</surname><given-names>Andrija</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<aff id="aff1"><institution>University Hospital of Split</institution>, <addr-line>Split</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Andrija Mateti&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Split, Spin&#x010D;i&#x0107;eva 1, HR-21000 Split, Croatia. / Phone: +385-98-9546-455 / E-mail: <email xlink:href="andrija.matetic@gmail.com">andrija.matetic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>03</month><year>2023</year></pub-date>
<volume>18</volume>
<issue>3-4</issue>
<fpage>89</fpage>
<lpage>90</lpage>
<history>
<date date-type="received"><day>14</day><month>02</month><year>2023</year></date>
<date date-type="accepted"><day>22</day><month>02</month><year>2023</year></date>
</history>
<permissions>
<copyright-year>2023</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>transcatheter aortic valve implantation</kwd><kwd>fully percutaneous</kwd><kwd>transaxillary approach</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Background</bold>: Fully percutaneous transaxillary approach for transcatheter aortic valve implantation (TAVI) has emerged as an alternative vascular access in patients with severely diseased femoral arteries (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). To the best of our knowledge, there were no previous cases of fully percutaneous transaxillary TAVI in Croatia.</p>
<p><bold>Case report</bold>: Two patients with severe symptomatic aortic stenosis and prohibitive surgical risk were evaluated. Transfemoral access was unfeasible due to extremely diseased femoral arteries. Surgeons were consulted for an alternative surgically mediated approach, but it was contemplated as unsuitable. Therefore, the patients were assigned to transaxillary TAVI. Procedural details: The procedures were conducted under the support of a highly experienced proctor in interventional cardiology. The staff received detailed instructions, and the Cath lab was specifically organized (<xref ref-type="fig" rid="f1"><bold>Figure 1</bold></xref>). The left radial approach was secured for safety and guidance. The left axillary artery was canulated using the standard set, under fluoroscopy and ultrasound guidance (<xref ref-type="fig" rid="f2"><bold>Figure 2</bold></xref>). Preclosure of axillary arteries was done using the two Perclose ProStyle&#x2122; devices, and the procedure was performed per standard local TAVI protocols (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) with successful valve implantation. The closure of the axillary artery was successfully done in one patient, while the failure of the Perclose ProStyle&#x2122; system induced vessel injury and persistent bleeding in another patient. Therefore, direct manual compression and two overlapping covered stents (Viabahn<sup>&#x00AE;</sup> 7x50mm and BeGraft<sup>&#x00AE;</sup> 8x37mm) were needed to achieve full hemostasis (<xref ref-type="fig" rid="f3"><bold>Figure 3</bold></xref>), without the need for surgical intervention. Procedural benefits included conscious sedation, limited staff utilization, lack of surgical incision, reduced infection risk, and constant bail-out option. Both patients were discharged within three postprocedural days, and the follow-up period was uneventful.</p>
<fig id="f1" position="float" fig-type="figure"><label>FIGURE 1</label><caption><p>Specific organization of the Cath lab for transaxillary transcatheter aortic valve intervention.</p></caption><graphic xlink:href="CC202218_3-4_89-90-f1"></graphic></fig>
<fig id="f2" position="float" fig-type="figure"><label>FIGURE 2</label><caption><p>Puncture method with anatomical landmarks.</p></caption><graphic xlink:href="CC202218_3-4_89-90-f2"></graphic></fig>
<fig id="f3" position="float" fig-type="figure"><label>FIGURE 3</label><caption><p>The closure and haemostasis of the axillary arteries.</p></caption><graphic xlink:href="CC202218_3-4_89-90-f3"></graphic></fig>
<p><bold>Conclusions</bold>: Fully percutaneous transaxillary TAVI is a viable alternative method for selected patients if transfemoral approach is unfeasible or surgically mediated options are unavailable. Although there are several benefits of this approach, it can be associated with serious complications requiring early proctoring support, high expertise and bail-out options.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seto</surname><given-names>AH</given-names></name><name><surname>Estep</surname><given-names>JD</given-names></name><name><surname>Tayal</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Messenger</surname><given-names>JC</given-names></name><name><surname>Chaidi Alraies</surname><given-names>M</given-names></name><etal/></person-group> <article-title>SCAI Position Statement on Best Practices for Percutaneous Axillary Arterial Access and Training.</article-title> <source>J Soc Cardiovasc Angiograph Interv.</source> <year>2022</year>;<volume>1</volume>(<issue>3</issue>):<elocation-id>100041</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.jscai.2022.100041</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkins</surname><given-names>B</given-names></name><name><surname>Bielauskas</surname><given-names>G</given-names></name><name><surname>Costa</surname><given-names>G</given-names></name><name><surname>Fukutomi</surname><given-names>M</given-names></name><name><surname>Sondergaard</surname><given-names>L</given-names></name><name><surname>De Backer</surname><given-names>O</given-names></name></person-group>. <article-title>Percutaneous Transaxillary versus Surgically-Assisted Transsubclavian TAVR: A Single Center Experience.</article-title> <source>Struct Heart</source>. <year>2021</year>;<volume>5</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1080/24748706.2020.1849882</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateti&#x0107;</surname><given-names>A</given-names></name><name><surname>Romi&#x0107;</surname><given-names>M</given-names></name><name><surname>Crn&#x010D;evi&#x0107;</surname><given-names>N</given-names></name><name><surname>Kristi&#x0107;</surname><given-names>I</given-names></name><name><surname>Tomuli&#x0107;</surname><given-names>V</given-names></name><name><surname>Runji&#x0107;</surname><given-names>F</given-names></name></person-group>. <article-title>Analgosedation during transcatheter aortic valve implantation: Review and protocol at University Hospital Centre Split.</article-title> <source>Cardiol Croat</source>. <year>2021</year>;<volume>16</volume>(<issue>9-10</issue>):<fpage>293</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.15836/ccar2021.293</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
